VNDA SG&A Expense Growth
Vanda Pharmaceuticals Inc · SG&A Expense Growth
VNDA SG&A Expense Growth
Latest reported62.52%period ending
VNDA FY SG&A Growth (YoY) (0.00% → 62.52%)
Latest values, visible window
High-resolution chart · PNG
VNDA sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 62.5193% | |
| 29.7042% | |
| -17.2927% | |
| 10.0268% | |
| -11.7166% | |
| 8.3046% | |
| 22.6806% | |
| -14.6074% | |
| 24.1053% | |
| 18.0478% | |
| -0.1335% | |
| 244.1652% | |
| 77.1647% | |
| 20.8602% | |
| 13.196% | |
| -57.2291% | |
| -17.9369% | |
| -11.8705% | |
| 140.5361% | |
| 84.3915% | |
| 248.9695% | |
| 0% |